The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria
Open accessAbstract
Macrophages (Mϕ) play a central role as effector cells in immunity to intracellular pathogens such as Mycobacterium. Paradoxically, they also provide a habitat for intracellular bacterial survival. This paradoxical role of Mϕ remains poorly understood. Here we report that this dual role may emanate from the functional plasticity of Mϕ: Whereas Mϕ-1 polarized in the presence of granulocyte–Mϕ colony-stimulating factor promoted type 1 immunity, Mϕ-2 polarized with Mϕ colony-stimulating factor subverted type 1 immunity and thus may promote immune escape and chronic infection. Importantly, Mϕ-1 secreted high levels of IL-23 (p40/p19) but no IL-12 (p40/p35) after (myco)bacterial activation. In contrast, activated Mϕ-2 produced neither IL-23 nor IL-12 but predominantly secreted IL-10. Mϕ-1 required IFN-γ as a secondary signal to induce IL-12p35 gene transcription and IL-12 secretion. Activated dendritic cells produced both IL-12 and IL-23, but unlike Mϕ-1 they slightly reduced their IL-23 secretion after addition of IFN-γ. Binding, uptake, and outgrowth of a mycobacterial reporter strain was supported by both Mϕ subsets, but more efficiently by Mϕ-2 than Mϕ-1. Whereas Mϕ-1 efficiently stimulated type 1 helper cells, Mϕ-2 only poorly supported type 1 helper function. Accordingly, activated Mϕ-2 but not Mϕ-1 down-modulated their antigen-presenting and costimulatory molecules (HLA-DR, CD86, and CD40). These findings indicate that (i)Mϕ-1 and Mϕ-2 play opposing roles in cellular immunity and (ii) IL-23 rather than IL-12 is the primary type 1 cytokine produced by activated proinflammatory Mϕ-1. Mϕ heterogeneity thus may be an important determinant of immunity and disease outcome in intracellular bacterial infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Self-citationOppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Self-citationTrinchieri, G. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001343 · Cited by 2,399
Flynn, J. L., & Chan, J. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 2,155
Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.287 · Cited by 1,960
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Self-citationThe many faces of macrophage activation
Mosser, D. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602325 · Cited by 1,902
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., & Ferrara, G. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020121 · Cited by 1,133
Terness, P., Bauer, T. M., Röse, L., Dufter, C., Watzlik, A., Simon, H., & Opelz, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020052 · Cited by 937
T-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signal
Kaliński, P., Hilkens, C. M. U., Wierenga, E. A., & Kapsenberg, M. L. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01547-9 · Cited by 933
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
Gu, L., Tseng, S., Horner, R. M., Tam, C., Loda, M., & Rollins, B. J. (2000) · Nature · doi:10.1038/35006097 · Cited by 832
Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis
Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3920 · Cited by 804
How can immunology contribute to the control of tuberculosis?
Kaufmann, S. H. E. (2001) · Nature Reviews Immunology · doi:10.1038/35095558 · Cited by 729
Goerdt, S., & Orfanos, C. E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80014-x · Cited by 682
Human macrophage activation programs induced by bacterial pathogens
Nau, G. J., Richmond, J. F. L., Schlesinger, A., Jennings, E. G., Lander, E. S., & Young, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022649799 · Cited by 568
Belkaid, Y., Hoffmann, K. F., Mendez, S., Kamhawi, S., Udey, M. C., Wynn, T. A., & Sacks, D. L. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1497 · Cited by 557
Giacomini, E., Iona, E., Ferroni, L., Miettinen, M., Fattorini, L., Orefici, G., Julkunen, I., & Coccia, E. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7033 · Cited by 433
A novel phenotype for an activated macrophage: the type 2 activated macrophage
Anderson, C. F., & Mosser, D. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.1.101 · Cited by 333
Hayes, M., Wang, J., & Norcross, M. (1995) · Blood · doi:10.1182/blood.v86.2.646.bloodjournal862646 · Cited by 329
Ting, L. M., Kim, A. C., Cattamanchi, A., & Ernst, J. D. (1999) · PubMed · Cited by 315
Decken, K., Köhler, G., Palmer-Lehmann, K., Wunderlin, A., Mattner, F., Magram, J., Gately, M. K., & Alber, G. (1998) · Infection and Immunity · doi:10.1128/iai.66.10.4994-5000.1998 · Cited by 311
Koppelman, B., Neefjes, J. J., de Vries, J. E., & de Waal Malefyt, R. (1997) · Immunity · doi:10.1016/s1074-7613(00)80404-5 · Cited by 307
Self-citationZhang, G.-X., Gran, B., Yu, S., Li, J., Siglienti, I., Chen, X., Kamoun, M., & Rostami, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2153 · Cited by 305
Cooper, A. M., Kipnis, A., Turner, J., Magram, J., Ferrante, J., & Orme, I. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1322 · Cited by 304
Wiekowski, M. T., Leach, M. W., Evans, E. W., Sullivan, L., Chen, S.-C., Vassileva, G., Bazan, J. F., Gorman, D. M., Kastelein, R. A., Narula, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7563 · Cited by 295
Self-citationSnijders, A., Hilkens, C. M., van der Pouw Kraan, T. C., Engel, M., Aarden, L. A., & Kapsenberg, M. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1207 · Cited by 288
Ting, L.-M., Kim, A. C., Cattamanchi, A., & Ernst, J. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3898 · Cited by 257
Ottenhoff, T. H. M., Verreck, F. A. W., Lichtenauer-Kaligis, E. G. R., Hoeve, M. A., Sanal, O., & van Dissel, J. T. (2002) · Nature Genetics · doi:10.1038/ng0902-97 · Cited by 246
Self-citationHuman T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin
Lamb, J. R., Eckels, D. D., Lake, P., Woody, J. N., & Green, N. (1982) · Nature · doi:10.1038/300066a0 · Cited by 223
The control of T cell responses by dendritic cell subsets
Reid, S. D., Penna, G., & Adorini, L. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00059-x · Cited by 216
Hickman, S. P., Chan, J., & Salgame, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4636 · Cited by 200
Rutledge, B. J., Rayburn, H., Rosenberg, R., North, R. J., Gladue, R. P., Corless, C. L., & Rollins, B. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4838 · Cited by 189
Increased Antimycobacterial Immunity in Interleukin-10-Deficient Mice
Murray, P. J., & Young, R. A. (1999) · Infection and Immunity · doi:10.1128/iai.67.6.3087-3095.1999 · Cited by 186
Assessment of Immunity to Mycobacterial Infection with Luciferase Reporter Constructs
Snewin, V. A., Gares, M.-P., ÓGaora, P., Hasan, Z., Brown, I. N., & Young, D. B. (1999) · Infection and Immunity · doi:10.1128/iai.67.9.4586-4593.1999 · Cited by 177
In vivo properties of monocyte chemoattractant protein-1
Gu, L., RUTLEDGE, B. J., Fiorillo, J., Ernst, C. A., Grewal, I. S., Flavell, R. A., Gladue, R. P., & Rollins, B. J. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.577 · Cited by 155
Immune responses to intracellular bacteria
Raupach, B., & Kaufmann, S. H. E. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00236-3 · Cited by 147
Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells
Ottenhoff, T. H. M., Klatser, P. R., Iványi, J., Elferink, D. G., de Wit, M. Y. L., & de Vries, R. R. P. (1986) · Nature · doi:10.1038/319066a0 · Cited by 113
Self-citationScheerens, H., Hessel, E. M., Malefyt, R. D. W., Leach, M. W., & Rennick, D. M. (2001) · European Journal of Immunology · Cited by 105
Toll-like receptors: mammalian 'taste receptors' for a smorgasbord of microbial invaders
Sieling, P. A., & Modlin, R. L. (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00288-6 · Cited by 86
Lim, W., Ma, W., Gee, K., Aucoin, S., Nandan, D., Díaz‐Mitoma, F., Kozlowski, M., & Kumar, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1759 · Cited by 46
Culture at High Density Improves the Ability of Human Macrophages to Control Mycobacterial Growth
Boéchat, N., Bouchonnet, F., Bonay, M., Grodet, A., Pelicic, V., Gicquel, B., & Hance, A. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6203 · Cited by 25
Cited by
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Martinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
Italiani, P., & Boraschi, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00514 · Cited by 2,067
Metadata
- Authors
- Verreck, F. A. W., de Boer, T., Langenberg, D. M. L., Hoeve, M. A., Kramer, M., Vaisberg, E., Kastelein, R., Kolk, A., de Waal-Malefyt, R., & Ottenhoff, T. H. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-03-19
- Volume
- 101
- Issue
- 13
- Pages
- 4560-4565
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2151948277
- Cited by
- 977
- References
- 49
- FWCI
- 16.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.